ID: ea633ba2-44f4-4a74-b096-dd319318ca97

GOLD TABLE:
|           | Language       | Pretrained from                | Corpora                                                     | Publicly Available   | Evaluation                                                                                     |
|----------:|:---------------|:-------------------------------|:------------------------------------------------------------|:---------------------|:-----------------------------------------------------------------------------------------------|
| 211678011 | ['Japanese']   | ['Scratch']                    | ['Japanese Clinical Text + Japanese Wikipedia']             | ['No']               | ['Text Classification']                                                                        |
| 226283634 | ['Portuguese'] | ['Multilingual BERT']          | ['Brazilian Clinical Text + Biomedical Text']               | ['Yes']              | ['Clinical Concept Extraction']                                                                |
| 215416118 | ['Russian']    | ['Multilingual BERT']          | ['Russian and English Health Reviews']                      | ['Yes']              | ['ADR Tweets Classification']                                                                  |
| 225452639 | ['German']     | ['General German BERT']        | ['Private Radiology Reports']                               | ['No']               | ['Radiology Reports Classification']                                                           |
| 218564040 | ['Spanish']    | ['Scratch']                    | ['Spanish Biomedical Text']                                 | ['No']               | ['Biomedical NER']                                                                             |
| 232283435 | ['Arabic']     | ['AraBERT']                    | ['General Arabic Text+ Arabic Biomedical Text']             | ['No']               | ['Biomedical NER']                                                                             |
| 219956480 | ['French']     | ['CamemBERT {{cite:a40b78e}}'] | ['French Biomedical Corpus']                                | ['No']               | ['Biomedical NER']                                                                             |
| 221293343 | ['Chinese']    | ['General Chinese BERT']       | ['Chinese Biomedical Text, Encyclopedia , Medical records'] | ['Yes']              | ['ChineseBLUE']                                                                                |
| 220409271 | ['Japanese']   | ['Scratch']                    | ['Japanese Clinical Text']                                  | ['Yes']              | ['Text Classification']                                                                        |
| 233240721 | ['Persian']    | ['ParsBERT {{cite:d02ce8d}}']  | ['Persian Medical Corpus']                                  | ['No']               | ['Medical Question Classification, Medical Question Retrieval and Medical Sentiment Analysis'] |
| 235077408 | ['Spanish']    | ['XLM-R {{cite:e715160}}']     | ['Spanish Clinical Text corpus']                            | ['Yes']              | ['Medical Coding']                                                                             |

GOLD SCHEMA:
0: Language
1: Pretrained from
2: Corpora
3: Publicly Available
4: Evaluation

PREDICTION PATH:../../metric_validation_0/ea633ba2-44f4-4a74-b096-dd319318ca97/mixtral/ours_outputs/try_0.json

PREDICTED TABLE:
|          | NER model and approach                    | Entity categories and subtypes                                                                               | F1-score and evaluation results                                                                                                                                                                                   | Use of context in NER                                                                                                                                               | Error analysis and model improvement strategies                                                                                                      |
|:---------|:------------------------------------------|:-------------------------------------------------------------------------------------------------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------|
| Paper 1  | ['BERT-based model']                      | ['Diseases, Treatments']                                                                                     | ['85%']                                                                                                                                                                                                           | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |
| Paper 2  | ['BioBERTpt']                             | ['Clinical entities']                                                                                        | ['F1-measure of 2.72%']                                                                                                                                                                                           | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |
| Paper 3  | ['BioBERTpt']                             | ['Clinical entities']                                                                                        | ['F1-measure of 2.72%']                                                                                                                                                                                           | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |
| Paper 4  | ['BioBERTpt']                             | ['Clinical entities']                                                                                        | ['F1-measure of 2.72%']                                                                                                                                                                                           | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |
| Paper 5  | ['RuDR-BERT']                             | ['Drug therapy, Drug- and disease-related information']                                                      | ['Macro F1 score of 74.85%']                                                                                                                                                                                      | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |
| Paper 6  | ['RuDR-BERT']                             | ['Drug therapy, Drug- and disease-related information']                                                      | ['Macro F1 score of 68.82%']                                                                                                                                                                                      | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |
| Paper 7  | ['BERT']                                  | ['Congestion, Effusion, Consolidation, Pneumothorax']                                                        | ['Areas under the receiver operation characteristics curve of 0.98, 0.97, 0.97, and 0.99 for congestion, effusion, consolidation, and pneumothorax, respectively']                                                | ["The paper uses BERT to identify the most important findings in intensive care chest x-ray reports, but it doesn't explicitly discuss the use of context in NER."] | ['N/A']                                                                                                                                              |
| Paper 8  | ['BERT']                                  | ['Congestion, Effusion, Consolidation, Pneumothorax']                                                        | ['Areas under the receiver operation characteristics curve of 0.98, 0.97, 0.97, and 0.99 for congestion, effusion, consolidation, and pneumothorax, respectively']                                                | ["The paper uses BERT to identify the most important findings in intensive care chest x-ray reports, but it doesn't explicitly discuss the use of context in NER."] | ['N/A']                                                                                                                                              |
| Paper 9  | ['BERT']                                  | ['Pharmacological substances, Compounds, Proteins']                                                          | ['Better results than the NER model trained over the standard word embeddings']                                                                                                                                   | ['Yes, the paper discusses the technology of contextualized word embeddings, which transforms text to the form being effective for Deep Learning.']                 | ['Yes, the paper conducts an error analysis showing the origins of models’ errors and proposing strategies to further improve the model’s quality.'] |
| Paper 10 | ['BERT-based model']                      | ['Disease, Treatment']                                                                                       | ['Outperformed both models with 85% F1-score']                                                                                                                                                                    | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |
| Paper 11 | ['Contextualized French Language Models'] | ['Symptoms and signs, Pathology categories, Anatomy, Dose, Exam, Mode, Moment, Substance, Treatment, Value'] | ['F1-measure of 66% and 75% for subtasks 1 and 2, respectively, and an F1-measure of 72% if considered all categories']                                                                                           | ['Yes, the paper explores contextualized language models for NER in French biomedical text as part of the Défi Fouille de Textes challenge.']                       | ['N/A']                                                                                                                                              |
| Paper 12 | ['BERT']                                  | ['Biomedical concepts and terminologies']                                                                    | ['Significant gain on the ChineseBLUE benchmark']                                                                                                                                                                 | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |
| Paper 13 | ['Clinical specific BERT']                | ['Medical concerns']                                                                                         | ['Higher performances on the MedWeb task than the other nonspecific BERTs, but no significant differences were found']                                                                                            | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |
| Paper 14 | ['SINA-BERT']                             | ['Medical entities']                                                                                         | ['Outperforms BERT-based models that were previously made available in the Persian language']                                                                                                                     | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |
| Paper 15 | ['mBERT, BETO, XLM-R']                    | ['Clinical coding entities']                                                                                 | ['MAP scores of 0.662, 0.544 and 0.884 on CodiEsp-D, CodiEsp-P and Cantemist-Coding shared tasks, respectively, which improved the previous state-of-the-art performance by 11.6%, 10.3% and 4.4%, respectively'] | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |
| Paper 16 | ['mBERT, neuen BETO und XLM-R']           | ['Clinical coding entities']                                                                                 | ['MAP scores of 0.662, 0.544 and 0.884 on CodiEsp-D, CodiEsp-P and Cantemist-Coding shared tasks, respectively, which improved the previous state-of-the-art performance by 11.6%, 10.3% and 4.4%, respectively'] | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |
| Paper 17 | ['mBERT, BETO, XLM-R']                    | ['Clinical coding entities']                                                                                 | ['MAP scores of 0.662, 0.544 and 0.884 on CodiEsp-D, CodiEsp-P and Cantemist-Coding shared tasks, respectively, which improved the previous state-of-the-art performance by 11.6%, 10.3% and 4.4%, respectively'] | ['N/A']                                                                                                                                                             | ['N/A']                                                                                                                                              |

MATCHES:
NER model and approach: 
Entity categories and subtypes: 
F1-score and evaluation results: 
Use of context in NER: 
Error analysis and model improvement strategies: 